hKIS compositions and methods of use

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C536S023500, C604S064000, C604S096010, C604S097020, C623S001150, C623S001350, C623S001460, C424S093210, C514S04400A

Reexamination Certificate

active

06894154

ABSTRACT:
Disclosed herein are novel composition and methods for altering the proliferation of a cell. Included are wild-type and mutant hKIS polypeptides along with cyclin kinase inhibitors containing mutations that prevent their inhibition with serine/threonine kinases.

REFERENCES:
patent: 5985635 (1999-11-01), Bandman et al.
patent: WO 9510623 (1995-04-01), None
Mahairas, G.G., EST database: Accession # AQ024916, submitted Jun. 1998.
Orkin et al., Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy, www.nih.gov Dec. 1995.
Verma, M. et al., Gene Therapy: Promises, Problems and Prospects, Nature, vol. 389, Sep. 1997, pp 239-242.
Eck, S. L. et al., 1996, Ch 5. Gene Based Therapy, Goodman & Gillman's The Pharmacological Basis of Therapeutics. pp 77-101.
Mahairas, G.G. et al., HS_2183_A2-B07_MF CIT Approved Human Genomic Sperm Library DHomo SapiensGenomic Clone, database sheet, XP-002125938, Jun. 23, 1998.
Hiller, K. et al., Soars Total Fetus Nb2HF8 9wHomo SapienscDNA Clone, database sheet, XP-002125939, Jun. 11, 1997.
Hiller, K. et al., Soars Total Fetus Nb2HF8 9wHomo SapienscDNA Clone, database sheet, XP-002125940, Jun. 11, 1997.
Maucuer, A. et al., KIS is a Protein Kinase with an RNA Recognition Motif, The Journal of Biol. Chem., vol. 272, No. 37, Sep. 12, 1997, pp 23151-23156.
Muller, D. et al., Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes, Oncogene, 15, pp 2561-2576, 1997.
Sheaff, R. et al., Cyclin E-CDK2 is a regulator of p27Kip, Genes and Development, 11, pp 1464-1478, 1997.
Polyak, K. et al., Cloning of p27Kip1, a Cyclin-Dependent Kinase Inhibitor and a Potentail Mediator of Extracellular Antimitogenic Signals, Cell. vol. 87, pp 59-66, Jul. 15, 1994.
PCT International Search Report for PCT/US99/18903, 1999.
Boehm, M. et al., A Growth Factor-Dependent Nuclear Kinase Phosphorylates p27Kip1and Regulates Cell Cycle Progression, The EMBO Journal, vol. 21, No. 13, pp. 3390-3401, 2002.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

hKIS compositions and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with hKIS compositions and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and hKIS compositions and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3409668

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.